Skip to main navigation
menu

Aclaris - Corp Menu

  • About Us »
    « Back
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Compliance
    • Contact
  • Research and Development »
    « Back
    • Drug Development Pipeline
    • Investigational Drug Candidates
    • Diseases and Conditions
    • Clinical Trials
    • Drug Discovery
    • Expanded Access
    • Investigator Initiated Studies
    • Publications
  • Partnerships
  • Careers
  • Citizenship »
    « Back
    • Scientist Development Program
    • Aclaris Support
  • Investors »
    « Back
    • Investor Overview
    • Stock Information
    • Press Releases
    • Events
    • Investor Presentations
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
    • Email Alerts

Aclaris - Extras Menu

  • Media resources
  • Contact us

Aclaris - Corp Menu

  • About Us »
    « Back
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Compliance
    • Contact
  • Research and Development »
    « Back
    • Drug Development Pipeline
    • Investigational Drug Candidates
    • Diseases and Conditions
    • Clinical Trials
    • Drug Discovery
    • Expanded Access
    • Investigator Initiated Studies
    • Publications
  • Partnerships
  • Careers
  • Citizenship »
    « Back
    • Scientist Development Program
    • Aclaris Support
  • Investors »
    « Back
    • Investor Overview
    • Stock Information
    • Press Releases
    • Events
    • Investor Presentations
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
    • Email Alerts

Aclaris - Investor Relations

  • Investor Overview
  • Stock Information
  • Press Releases
  • Events
  • SEC Filings
  • Corporate Governance
  • Investor Presentations
  • Investor FAQs
  • Email Alerts
Investor Contact
For investor related questions, please email
investors@aclaristx.com

Highlights

Highlights

Governance Documents
Bylaws 260.7 KB
Charter 2.8 MB
Code of Business Conduct and Ethics 772.6 KB
Corporate Governance Guidelines 127.1 KB
Whistleblower Policy 602.8 KB
Committee Charters
Audit Committee Charter 206.8 KB
Compensation Committee Charter 220 KB
Nominating and Corporate Governance Committee Charter 35.6 KB
Committee Composition
Audit Compensation Nominating and Corporate Governance
Maxine Gowen Audit
William Humphries Compensation Nominating and Corporate Governance
Anand Mehra Compensation
Vincent Milano Audit
Christopher Molineaux Audit Nominating and Corporate Governance
= Chairperson = Member

Aclaris - Footer Menu

  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Fraudulent Activity Notice
© 2026 Aclaris Therapeutics, Inc. All rights reserved. Unless otherwise noted, all trademarks referenced on this page are owned by Aclaris Therapeutics.